T. E. Davis

1.5k total citations
27 papers, 1.1k citations indexed

About

T. E. Davis is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, T. E. Davis has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in T. E. Davis's work include Cancer Treatment and Pharmacology (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Estrogen and related hormone effects (4 papers). T. E. Davis is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Estrogen and related hormone effects (4 papers). T. E. Davis collaborates with scholars based in United States, Chile and Cameroon. T. E. Davis's co-authors include David P. Rose, DeAnna D. Fuller, Geoffrey Falkson, D C Tormey, D. Fuller, Dennis L. Citrin, H. Ian Robins, Warren H. Dennis, H. C. Falkson and Julie A. Ribes and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

T. E. Davis

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. E. Davis United States 18 383 308 301 172 139 27 1.1k
A. J. M. Eerenberg Netherlands 19 503 1.3× 150 0.5× 111 0.4× 97 0.6× 79 0.6× 21 1.8k
Jānis Gardovskis Latvia 16 140 0.4× 253 0.8× 235 0.8× 118 0.7× 138 1.0× 93 1.1k
Eduardo Reyes Chile 19 305 0.8× 188 0.6× 170 0.6× 107 0.6× 72 0.5× 73 1.1k
B. Kubanek Germany 25 276 0.7× 94 0.3× 258 0.9× 60 0.3× 298 2.1× 138 2.1k
Carlos Rodríguez‐Gallego Spain 27 379 1.0× 167 0.5× 223 0.7× 125 0.7× 129 0.9× 77 1.6k
Carsten Ziske Germany 22 426 1.1× 186 0.6× 929 3.1× 89 0.5× 176 1.3× 52 1.6k
G. de Stefano Italy 26 643 1.7× 152 0.5× 162 0.5× 111 0.6× 35 0.3× 60 1.6k
Shun‐ichi Kimura Japan 19 358 0.9× 115 0.4× 250 0.8× 44 0.3× 66 0.5× 105 1.2k
Luca Mele Italy 17 386 1.0× 413 1.3× 198 0.7× 49 0.3× 60 0.4× 31 1.2k
Marcus Gorschlüter Germany 20 486 1.3× 391 1.3× 910 3.0× 62 0.4× 161 1.2× 44 1.6k

Countries citing papers authored by T. E. Davis

Since Specialization
Citations

This map shows the geographic impact of T. E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. E. Davis more than expected).

Fields of papers citing papers by T. E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. E. Davis. The network helps show where T. E. Davis may publish in the future.

Co-authorship network of co-authors of T. E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of T. E. Davis. A scholar is included among the top collaborators of T. E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. E. Davis. T. E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Hage, Chadi A., Julie A. Ribes, Nancy L. Wengenack, et al.. (2011). A Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis. Clinical Infectious Diseases. 53(5). 448–454. 248 indexed citations
4.
Fuller, DeAnna D., T. E. Davis, Pamela Kibsey, et al.. (1994). Comparison of BACTEC Plus 26 and 27 media with and without fastidious organism supplement with conventional methods for culture of sterile body fluids. Journal of Clinical Microbiology. 32(6). 1488–1491. 26 indexed citations
5.
Cummings, F J, Robert J. Gray, D C Tormey, et al.. (1993). Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.. Journal of Clinical Oncology. 11(1). 29–35. 93 indexed citations
6.
Wilson, Michael L., T. E. Davis, S Mirrett, et al.. (1993). Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. Journal of Clinical Microbiology. 31(4). 865–871. 44 indexed citations
7.
Davis, T. E. & DeAnna D. Fuller. (1991). Direct identification of bacterial isolates in blood cultures by using a DNA probe. Journal of Clinical Microbiology. 29(10). 2193–2196. 64 indexed citations
8.
Trump, D L, Paul Elson, Ernest C. Borden, et al.. (1987). High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study.. PubMed. 71(2). 165–9. 21 indexed citations
9.
Loprinzi, Charles L., D C Tormey, Paul W. Rasmussen, et al.. (1986). Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.. Journal of Clinical Oncology. 4(1). 46–56. 59 indexed citations
10.
Robins, H. Ian, Warren H. Dennis, A. J. Neville, et al.. (1985). A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.. PubMed. 45(8). 3937–44. 98 indexed citations
11.
Palta, Mari, et al.. (1985). Short term high density systemic therapy for metastatic breast cancer. Breast Cancer Research and Treatment. 5(2). 177–188. 15 indexed citations
12.
Robins, H. Ian, et al.. (1983). Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model.. PubMed. 43(5). 2018–22. 30 indexed citations
13.
Robins, H. Ian, Linda M. Shecterle, James P. AuBuchon, et al.. (1983). Whole Body Hyperthermia with a Microwave Regional Boost: Unexpected Toxicity in the Pig. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 44(5). 469–473. 3 indexed citations
14.
Davis, T. E., et al.. (1982). Spontaneous retroperitoneal hemorrhage: A case report. Journal of Surgical Oncology. 21(1). 27–29. 8 indexed citations
15.
Koeller, Jim M., et al.. (1981). Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluation.. PubMed. 65(7-8). 651–3. 24 indexed citations
16.
Rose, David P. & T. E. Davis. (1979). Plasma triiodothyronine concentrations in breast cancer. Cancer. 43(4). 1434–1438. 22 indexed citations
17.
Rose, David P. & T. E. Davis. (1977). OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER. The Lancet. 309(8023). 1174–1176. 114 indexed citations
18.
Rose, David P. & T. E. Davis. (1977). OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER. Obstetrical & Gynecological Survey. 32(11). 766–766. 2 indexed citations
19.
Santos, G. W., LL Sensenbrenner, P. J. Burke, et al.. (1974). Allogeneic marrow grafts in man using cyclophosphamide.. PubMed. 6(4). 345–8. 22 indexed citations
20.
Davis, T. E., et al.. (1970). Bone resorption in hypovitaminosis A.. PubMed. 60(1). 90–119. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026